← back to database
The culture at Samara BioCapital is critical to our shared vision to have a significant impact on the lives of patients. We recognize that we accomplish this only indirectly, but we feel incredibly fortunate and grateful to have the opportunity to be investing in a remarkably prolific time for biotech innovation, and to work with inspiring companies as they develop important and innovative new therapies.
Primary stage
Lead / follow
Hardware / software
Investment focus
Investors
Srini Akkaraju, Mike Dybbs, Cory Freedland, Abe Bassan